Prothena Corp

PRTA NASDAQ
9.40
-0.56
-5.62%
盘后: 9.40 0 0.00% 16:23 06/14 EDT
开盘
9.98
昨收
9.96
最高
9.98
最低
9.37
成交量
30.82万
成交均量(3M)
28.47万
52周最高
15.91
52周最低
8.63
换手率
0.77%
市值
3.75亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Prothena Corp PRTA股票价格,Prothena Corp股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Prothena Corporation Public Limited Company is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. The Company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). The Company has generated monoclonal antibodies that selectively bind to amyloidogenic (diseased) forms of the Transthyretin (TTR)-mediated amyloidosis (ATTR) protein. The Company's pipeline also includes late discovery-stage programs for which the Company is testing the efficacy of antibodies in preclinical models of diseases related to amyloid or cell adhesion.
展开 >

最近浏览

名称
价格
涨跌幅